PolyPeptide Group AG engages in the business of development, manufacturing, and marketing of peptide- and oligonucleotide-based compounds for use in the pharmaceutical and related research industries. It operates through the following business areas: Custom Projects, Contract Manufacturing, and Generics and Cosmetics. The Custom Projects business area includes manufacturing of custom research-grade peptides and oligonucleotides for use in pre-clinical and clinical development as well as for regulatory and scientific studies. The Contract Manufacturing business area focuses on peptides for commercial stage peptide therapeutics, at scale, in commercial batches and in accordance with current Good Manufacturing Practice (cGMP) requirements. The Generics and Cosmetics business area is involved in peptide-based generics for the human and veterinary market, produced on an industrial scale following cGMP guidelines. The company was founded in 1952 and is headquartered in Baar, Switzerland.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
1,362
Frequently Asked Questions
What is Market Cap of PolyPeptide Group AG?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. PolyPeptide Group AG market cap is $1.13B.
What is the 52-week high for PolyPeptide Group AG?
52 week high is the highest price of a stock in the past 52 weeks, or one year. PolyPeptide Group AG 52 week high is $34.25 as of October 01, 2025.
What is the 52-week low for PolyPeptide Group AG?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. PolyPeptide Group AG 52 week low is $34.25 as of October 01, 2025.
What is PolyPeptide Group AG stock price today?
PolyPeptide Group AG stock price today is $34.25.
What is the PE ratio of PolyPeptide Group AG?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. PolyPeptide Group AG’s P/E ratio is -29.86.
What is the Price-to-Book ratio of PolyPeptide Group AG?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. PolyPeptide Group AG P/B ratio is 2.9083.
What is the 50-day moving average of PolyPeptide Group AG?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. PolyPeptide Group AG 50-day moving average is $16.44.